Differences in effects of Ca2+ channel antagonists on dopamine metabolism in the limbic and extrapyramidal dopaminergic structures

Psychopharmacology

Volumn 128, Issue 1, 1996, Pages 39-44

  Antkiewicz Michaluk, Lucyna ^a   Romańska, Irena ^a   Vetulani, Jerzy ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Chronic treatment; Dopamine metabolism; Limbic structures; Nifedipine; Verapamil

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE; HOMOVANILLIC ACID; NIFEDIPINE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOSE TIME EFFECT RELATION; EXTRAPYRAMIDAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; TISSUE SPECIFICITY; ANIMAL; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; WISTAR RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; CORPUS STRIATUM; DOPAMINE; HOMOVANILLIC ACID; MALE; NIFEDIPINE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; VERAPAMIL;

EID: 0029658734     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050107     Document Type: Article

References (43)

1. Antkiewicz-Michaluk L, Michaluk J, Romaska I, Vetulani J (1990) Cortical dihydropyridine binding sites and behavioral syndrome in morphine abstinent rat. Eur J Pharmacol 180:129-135
2. Antkiewicz-Michaluk L, Romanska I, Michaluk J, Vetulani J (1991) Role of calcium channels in effects of antidepressant drugs on responsiveness to pain. Psychopharmacology 105: 269-274
3. Antkiewicz-Michaluk L, Michaluk J, Romanska I, Vetulani J (1993) Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine. Psychopharmacology 111:457-464
4. Antkiewicz-Michaluk L, Michaluk J, Romanska I, Vetulani J (1994a) Differential involvement of voltage-dependent calcium channels in apomorphine-induced hypermotility and stereotypy. Psychopharmacology 113:555-560
5. Antkiewicz-Michaluk L, Michaluk J, Vetulani J (1994b) Modification of effects of chronic electroconvulsive shock by voltage dependent calcium channel blockade with nifedipine. Eur J Pharmacol 254:9-16
6. Bannon MJ, Bunney EB, Roth RH (1981) Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems. Brain Res 218:376-382
7. Biegon A, Israeli M (1986) Localization of the effects of electroconvulsive shock on β-adrenoceptors in the rat brain. Eur J Pharmacol 123:329-334
8. Biegon A, Israeli M (1988) Regionally selective increases in β-adrenergic receptor density in the brains of suicide victims. Brain Res 442:199-203
9. Bongianni F, Carla V, Moroni F, Pellegrini-Giampietro DE (1986) Calcium channel inhibitors suppress the morphine withdrawal syndrome in rats. Br J Pharmacol 88: 561-567
10. 3H]dopamine release from rat mcsencephalic cells in primary culture. J Neurochem 62:1416-1425
11. Calcagnetti DJ, Schlechter MD (1992) Attenuation of drinking sweetened water following calcium channel blockade. Brain Res Bull 28:967-973
12. Chesselet MF (1984) Presynaptic regulation of neurotransmitter release in the brain: facts and hypotheses. Neuroscience 12:347-375
13. Chiodo LA, Bunney BS (1983) Typical and atypical neurolepties: differential effects of chronic administration on the activity of A9 and AlO midbrain dopaminergic neurons. J Neurosci 3:1607-1619
14. Chiodo LA, Bannon MJ, Grace AA, Roth RH, Bunney BS (1984) Evidence for the absence of impulse regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulation of mesocortical dopamine neurons. Neuroscience 12:1-16
15. Contreras E, Tamao L, Amigo M (1988) Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance. Eur J Pharmacol 148:463-466
16. Czyrak A (1993) The effect of chronic nifedipine and ECS in the forced swimming test in rats. Pol J Pharmacol 45: 191-195
17. Czyrak A, Mogilnicka E, Maj J (1989) Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats. Neuropharmacology 28:229-233
18. Czyrak A, Mogilnicka E, Siwanowicz J, Maj J (1990) Some behavioral effects of repeated administration of calcium channel antagonists. Pharmacol Biochem Behav 35: 557-560
19. Czyrak A, Rogóz Z, Skuza G, Zajaczkowski W, Maj J (1992) Antidepressant activity of S-adenosyl-L-methionine in mice and rats. J Basic Clin Physiol Pharmacol 3:1-17
20. 3H]spiperone binding to D-2 receptors in striatal homogenates by calcium channel antagonists and polyvalent cations. Eur J Pharmacol 106:133-139
21. DiChiara G, North RA (1992) Neurobiology of opiate abuse. Trends Pharmacol 13:185-193
22. DiLullo SL, Martin-Iverson MT (1992) Calcium channel blockade interacts with a neuroleptic to attenuate the conditioning of amphetamine's behavioral effects in the rat. Biol Psychiatry 31:1143-1150
23. Dinan TG, Capstick C (1989) A pilot study of verapamil in the treatment of tardive dyskinesia. Hum Psychopharmacol 4:55-58
24. Gaggi R, Gianni AM (1990) Effects of calcium antagonists on biogenic amines in discrete brain areas. Eur J Pharmacol 181: 187-197
25. Gaggi R, Gianni AM (1991) Effects of brain biogenic amines of repeated treatments with calcium antagonists. Jpn J Pharmacol 56:33-41
26. Gaggi R, Cont R, Gianni AM (1993) Comparison among the effects of nifedipine, nimodipine and nisoldipine on the brain biogenic amines of normal or haloperidol treated rats. Gen Pharmacol 24:1091-1096
27. Guerrero-Muñoz F, Adames C, Fearon Z, Way EL (1981) Calcium-opiate antagonism in the periaqueductal gray (PGA) region. Eur J Pharmacol 76:417-419
28. Janis RA, Triggle DJ (1991) Drugs acting on calcium channels. In: Hurwitz L, Cartridge LD, Leach JK (eds) Calcium channels: their properties, functions, regulation, and clinical relevance. CRC Press, Boca Raton, pp 195-249
29. Kato T, Otsu Y, Furune Y, Yamamoto T (1992) Different effects of L-, N- and T-type calcium channel blockers on striatal dopamine release measured by microdialysis in freely moving rais. Neurochem Int 21:99-107
30. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723
31. Koob GF, Maldonado R, Stinus L (1992) Neuronal substrate of opiate withdrawal. Trends Neuropharmacol 15:186-191
32. Kuzmin A, Zvartau E, Gessa GL, Martellotta MC, Fratta W (1992) Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous sell-administration in drug-naive mice. Pharmacol Biochem Behav 41:497-500
33. Maj J, Rogóz Z, Skuza G, Sowinska H (1984a) Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine. J Pharm Pharmacol 36:127-130
34. Maj J, Rogóz Z, Skuza G, Sowinska H (1984b) Repeated treatment with antidepressant drugs increases the behavioral response to apomorphine. J Neural Transm 60:273-282
35. Mamczarz J, Kurolewicz B, Antkiewicz-Michaluk L, Vetulani J (1994) Co-administration of nifedipine with neuroleptics prevents development of activity changes during withdrawal. Pol J Pharmacol 46:75-77
36. Muller P, Seeman P (1977) Dopaminergic supersensitivity after neuroleptics: time course and specificity. Psychopharmacology 60: 1-11
37. Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391
38. Przegalinski E, Baran L, Siwanowicz J, Nowak G, Antkiewicz-Michaluk L, Vetulani J (1985) Chronic treatment with the potential antidepressant drug rolipram: the effect on the behavioral responses to adrenergie and dopaminergic receptor agonists with some biochemical correlates. J Neural Transm 64: 211-226
39. Sharp T, Bennett GW, Marsden CA (1982) Thyrotrophin-releasing hormone analogues increase dopamine release from slices of rat brain. J Neurochem 39: 1763-1766
40. 2-autoreceptors and guanosine triphosphate-binding proteins. Jpn Circ J 56:248-254
41. Tsuda K, Tsuda S, Goldstein M, Masuyama V (1993) Effects of verapamil and diltiazem on dopamine release in the central nervous system of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 20:641-645
42. Whittington SJ, Dolin MA, Patch TL, Siarey RJ, Butterworth AR, Little HJ (1991) Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment. Br J Pharmacol 103:1669-1676
43. Wielosz M (1981) Increased sensitivity to dopamine agonists after repeated electroconvulsive shock in rat. Neuropharmacology 20:941-945